CFD
PCVX icon

Creative Financial Designs’s Vaxcyte PCVX Stock Holding History

Creative Financial Designs’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34K Buy
+23
New +$1.25K ﹤0.01% 1837
2025
Q2 		– Sell
-12
Closed -$453 – 2128
2025
Q1 		$453 Buy
+12
New +$959 ﹤0.01% 1920

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Creative Financial Designs's PCVX Position: Q1 2026 in Review

Creative Financial Designs opened a new position in Vaxcyte (PCVX) in Q1 2026: 23 shares worth $1.34K. The stake represents ﹤0.01% of the portfolio and ranks #1837 among its holdings. This is a return to the name: Creative Financial Designs previously reported a position in PCVX as recently as Q1 2025.

Creative Financial Designs first reported a position in PCVX in Q1 2025 and has held it in 2 quarters since. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Creative Financial Designs held 23 shares of Vaxcyte worth $1.34K as of Q1 2026.
  • Vaxcyte was a new Creative Financial Designs position in Q1 2026.
  • Vaxcyte made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #1837 holding.
  • Creative Financial Designs first reported a position in Vaxcyte in Q1 2025 and has held it in 2 quarters since.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.